Chemoinformaics analysis of 3beta-24-Methylenelanost-9(11)-en-3-ol
| Molecular Weight | 440.756 | nRot | 5 |
| Heavy Atom Molecular Weight | 388.34 | nRig | 21 |
| Exact Molecular Weight | 440.402 | nRing | 4 |
| Solubility: LogS | -6.388 | nHRing | 0 |
| Solubility: LogP | 7.524 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 87.2452 |
| nHD | 1 | BPOL | 52.1668 |
| QED | 0.424 |
| Synth | 4.722 |
| Natural Product Likeliness | 3.499 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.733 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.801 |
| MDCK | 0.00000843 |
| BBB | 0.735 |
| PPB | 0.993181 |
| VDSS | 1.751 |
| FU | 0.0182796 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.544 |
| CYP2c19-inh | 0.073 |
| CYP2c19-sub | 0.969 |
| CYP2c9-inh | 0.095 |
| CYP2c9-sub | 0.491 |
| CYP2d6-inh | 0.079 |
| CYP2d6-sub | 0.883 |
| CYP3a4-inh | 0.279 |
| CYP3a4-sub | 0.657 |
| CL | 11.293 |
| T12 | 0.006 |
| hERG | 0.006 |
| Ames | 0.016 |
| ROA | 0.352 |
| SkinSen | 0.029 |
| Carcinogencity | 0.037 |
| EI | 0.026 |
| Respiratory | 0.793 |
| NR-Aromatase | 0.248 |
| Antiviral | No |
| Prediction | 0.549733 |